Search research articles
Contact Us
Filters
Showing results (31-40 of 123) with videos related to
Page
of 13
Sort By:
Pharmaceutical Statistics
|
November 15, 2008
Application of optimal design methodologies in clinical pharmacology experiments
Kayode Ogungbenro, Aristides Dokoumetzidis, Leon Aarons
The AAPS Journal
|
November 22, 2014
Empirical and semi-mechanistic modelling of double-peaked pharmacokinetic profile phenomenon due to gastric emptying
Kayode Ogungbenro, Henry Pertinez, Leon Aarons
Pharmaceutical Research
|
May 6, 2014
Handling missing data in a duloxetine population pharmacokinetic/pharmacodynamic model - imputation methods and selection models
Eunice Yuen, Ivelina Gueorguieva, Leon Aarons
Biopharmaceutics & Drug Disposition
|
July 13, 2004
Pharmacodynamics of controlled release verapamil in patients with hypertension: an analysis using spline functions
Leon Aarons, Claire Baxter, Suneel Gupta
Archives of Medical Research
|
March 22, 2005
Estimation of population pharmacokinetic parameters of free-phenytoin in adult epileptic patients
Dirk Deleu, Leon Aarons, Ikhlas Ali Ahmed
British Journal of Clinical Pharmacology
|
September 17, 2013
Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data
Nikolaos Tsamandouras, Amin Rostami-Hodjegan, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics
|
August 2, 2015
Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics
Thierry Wendling, Swati Dumitras, Kayode Ogungbenro, et al.
Computer Methods and Programs in Biomedicine
|
September 6, 2005
The use of a modified Fedorov exchange algorithm to optimise sampling times for population pharmacokinetic experiments
Kayode Ogungbenro, Gordon Graham, Ivelina Gueorguieva, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 29, 2005
The pharmacokinetics of perindoprilat in normal volunteers and patients: influence of age and disease state
Eva Parker, Leon Aarons, Malcolm Rowland, et al.
Journal of Biopharmaceutical Statistics
|
March 11, 2008
Incorporating correlation in interindividual variability for the optimal design of multiresponse pharmacokinetic experiments
Kayode Ogungbenro, Gordon Graham, Ivelina Gueorguieva, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 123) with videos related to
Sort By:
Page
of 13
Pharmaceutical Statistics
|
November 15, 2008
Application of optimal design methodologies in clinical pharmacology experiments
Kayode Ogungbenro, Aristides Dokoumetzidis, Leon Aarons
The AAPS Journal
|
November 22, 2014
Empirical and semi-mechanistic modelling of double-peaked pharmacokinetic profile phenomenon due to gastric emptying
Kayode Ogungbenro, Henry Pertinez, Leon Aarons
Pharmaceutical Research
|
May 6, 2014
Handling missing data in a duloxetine population pharmacokinetic/pharmacodynamic model - imputation methods and selection models
Eunice Yuen, Ivelina Gueorguieva, Leon Aarons
Biopharmaceutics & Drug Disposition
|
July 13, 2004
Pharmacodynamics of controlled release verapamil in patients with hypertension: an analysis using spline functions
Leon Aarons, Claire Baxter, Suneel Gupta
Archives of Medical Research
|
March 22, 2005
Estimation of population pharmacokinetic parameters of free-phenytoin in adult epileptic patients
Dirk Deleu, Leon Aarons, Ikhlas Ali Ahmed
British Journal of Clinical Pharmacology
|
September 17, 2013
Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data
Nikolaos Tsamandouras, Amin Rostami-Hodjegan, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics
|
August 2, 2015
Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics
Thierry Wendling, Swati Dumitras, Kayode Ogungbenro, et al.
Computer Methods and Programs in Biomedicine
|
September 6, 2005
The use of a modified Fedorov exchange algorithm to optimise sampling times for population pharmacokinetic experiments
Kayode Ogungbenro, Gordon Graham, Ivelina Gueorguieva, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 29, 2005
The pharmacokinetics of perindoprilat in normal volunteers and patients: influence of age and disease state
Eva Parker, Leon Aarons, Malcolm Rowland, et al.
Journal of Biopharmaceutical Statistics
|
March 11, 2008
Incorporating correlation in interindividual variability for the optimal design of multiresponse pharmacokinetic experiments
Kayode Ogungbenro, Gordon Graham, Ivelina Gueorguieva, et al.
Page
of 13